BCLI Annual Current Liabilities
$7.80 M
-$1.00 M-11.36%
31 December 2023
Summary:
As of January 20, 2025, BCLI annual total current liabilities is $7.80 million, with the most recent change of -$1.00 million (-11.36%) on December 31, 2023. During the last 3 years, it has fallen by -$3.43 million (-30.56%). BCLI annual current liabilities is now -55.82% below its all-time high of $17.65 million, reached on December 31, 2019.BCLI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCLI Quarterly Current Liabilities
$7.08 M
-$609.00 K-7.92%
30 September 2024
Summary:
As of January 20, 2025, BCLI quarterly total current liabilities is $7.08 million, with the most recent change of -$609.00 thousand (-7.92%) on September 30, 2024. Over the past year, it has dropped by -$609.00 thousand (-7.92%). BCLI quarterly current liabilities is now -59.88% below its all-time high of $17.65 million, reached on December 31, 2019.BCLI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCLI Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.4% | -7.9% |
| 3 y3 years | -30.6% | -7.9% |
| 5 y5 years | +25.6% | -7.9% |
BCLI Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.4% | +23.5% | -32.0% | +12.1% |
| 5 y | 5-year | -55.8% | +23.5% | -59.9% | +21.1% |
| alltime | all time | -55.8% | -59.9% |
Brainstorm Cell Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.08 M(-7.9%) |
| June 2024 | - | $7.69 M(+12.6%) |
| Mar 2024 | - | $6.83 M(-12.4%) |
| Dec 2023 | $7.80 M(-11.4%) | $7.80 M(+23.4%) |
| Sept 2023 | - | $6.32 M(-17.8%) |
| June 2023 | - | $7.69 M(-26.2%) |
| Mar 2023 | - | $10.42 M(+18.4%) |
| Dec 2022 | $8.80 M(+39.3%) | $8.80 M(-1.7%) |
| Sept 2022 | - | $8.95 M(+14.0%) |
| June 2022 | - | $7.85 M(+6.4%) |
| Mar 2022 | - | $7.37 M(+16.7%) |
| Dec 2021 | $6.32 M(-43.8%) | $6.32 M(+8.1%) |
| Sept 2021 | - | $5.85 M(-27.5%) |
| June 2021 | - | $8.06 M(-1.6%) |
| Mar 2021 | - | $8.19 M(-27.1%) |
| Dec 2020 | $11.23 M(-36.4%) | $11.23 M(+74.7%) |
| Sept 2020 | - | $6.43 M(-27.3%) |
| June 2020 | - | $8.84 M(+7.1%) |
| Mar 2020 | - | $8.25 M(-53.3%) |
| Dec 2019 | $17.65 M(+184.2%) | $17.65 M(+47.6%) |
| Sept 2019 | - | $11.96 M(+13.4%) |
| June 2019 | - | $10.54 M(+24.3%) |
| Mar 2019 | - | $8.48 M(+36.5%) |
| Dec 2018 | $6.21 M(+12.1%) | $6.21 M(+63.9%) |
| Sept 2018 | - | $3.79 M(-53.5%) |
| June 2018 | - | $8.15 M(+46.0%) |
| Mar 2018 | - | $5.58 M(+0.6%) |
| Dec 2017 | $5.54 M(+541.6%) | $5.54 M(-9.7%) |
| Sept 2017 | - | $6.14 M(+763.6%) |
| June 2017 | - | $711.00 K(-9.9%) |
| Mar 2017 | - | $789.00 K(-8.7%) |
| Dec 2016 | $864.00 K(-70.7%) | $864.00 K(-27.7%) |
| Sept 2016 | - | $1.20 M(-6.8%) |
| June 2016 | - | $1.28 M(+3.2%) |
| Mar 2016 | - | $1.24 M(-57.9%) |
| Dec 2015 | $2.95 M(-5.2%) | $2.95 M(+4.0%) |
| Sept 2015 | - | $2.84 M(+12.4%) |
| June 2015 | - | $2.53 M(-7.3%) |
| Mar 2015 | - | $2.73 M(-12.4%) |
| Dec 2014 | $3.11 M(+133.7%) | $3.11 M(+30.0%) |
| Sept 2014 | - | $2.40 M(+34.4%) |
| June 2014 | - | $1.78 M(+10.9%) |
| Mar 2014 | - | $1.61 M(+20.6%) |
| Dec 2013 | $1.33 M | $1.33 M(-3.9%) |
| Sept 2013 | - | $1.39 M(+15.5%) |
| June 2013 | - | $1.20 M(+13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $1.06 M(-8.2%) |
| Dec 2012 | $1.16 M(+1.9%) | $1.16 M(+5.3%) |
| Sept 2012 | - | $1.10 M(-24.3%) |
| June 2012 | - | $1.45 M(+12.4%) |
| Mar 2012 | - | $1.29 M(+13.7%) |
| Dec 2011 | $1.14 M(-20.2%) | $1.14 M(+40.5%) |
| Sept 2011 | - | $808.00 K(-36.7%) |
| June 2011 | - | $1.28 M(-20.7%) |
| Mar 2011 | - | $1.61 M(+13.1%) |
| Dec 2010 | $1.42 M(-40.4%) | $1.42 M(-25.5%) |
| Sept 2010 | - | $1.91 M(+2.5%) |
| June 2010 | - | $1.86 M(-0.5%) |
| Mar 2010 | - | $1.87 M(-21.6%) |
| Dec 2009 | $2.39 M(-16.5%) | $2.39 M(-27.0%) |
| Sept 2009 | - | $3.27 M(+8.2%) |
| June 2009 | - | $3.02 M(-0.6%) |
| Mar 2009 | - | $3.04 M(+6.4%) |
| Dec 2008 | $2.86 M(-11.4%) | $2.86 M(+5.8%) |
| Sept 2008 | - | $2.70 M(+4.8%) |
| June 2008 | - | $2.58 M(-24.8%) |
| Mar 2008 | - | $3.43 M(+6.2%) |
| Dec 2007 | $3.23 M(+29.3%) | $3.23 M(+20.5%) |
| Sept 2007 | - | $2.68 M(-26.6%) |
| June 2007 | - | $3.65 M(+16.4%) |
| Mar 2007 | - | $3.13 M(+48.4%) |
| Dec 2006 | $2.50 M(+134.0%) | - |
| Sept 2006 | - | $2.11 M(+25.9%) |
| June 2006 | - | $1.68 M(+57.2%) |
| Mar 2006 | - | $1.07 M(+46.4%) |
| Mar 2006 | $1.07 M(+530.9%) | - |
| Dec 2005 | - | $728.80 K(+24.3%) |
| Sept 2005 | - | $586.10 K(+36.9%) |
| June 2005 | - | $428.00 K(+153.1%) |
| Mar 2005 | $169.10 K(>+9900.0%) | $169.10 K(+56.3%) |
| Dec 2004 | - | $108.20 K(+540.2%) |
| Sept 2004 | - | $16.90 K(+238.0%) |
| June 2004 | - | $5000.00(>+9900.0%) |
| Mar 2004 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2003 | - | $38.40 K(+8.5%) |
| Sept 2003 | - | $35.40 K(+30.1%) |
| June 2003 | - | $27.20 K(+8.4%) |
| Mar 2003 | $25.10 K(+118.3%) | $25.10 K(+263.8%) |
| Dec 2002 | - | $6900.00(-60.6%) |
| Sept 2002 | - | $17.50 K(+236.5%) |
| June 2002 | - | $5200.00 |
| Mar 2002 | $11.50 K | - |
FAQ
- What is Brainstorm Cell Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual current liabilities year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly current liabilities year-on-year change?
What is Brainstorm Cell Therapeutics annual total current liabilities?
The current annual current liabilities of BCLI is $7.80 M
What is the all time high annual current liabilities for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual total current liabilities is $17.65 M
What is Brainstorm Cell Therapeutics annual current liabilities year-on-year change?
Over the past year, BCLI annual total current liabilities has changed by -$1.00 M (-11.36%)
What is Brainstorm Cell Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of BCLI is $7.08 M
What is the all time high quarterly current liabilities for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly total current liabilities is $17.65 M
What is Brainstorm Cell Therapeutics quarterly current liabilities year-on-year change?
Over the past year, BCLI quarterly total current liabilities has changed by -$609.00 K (-7.92%)